Evaluation of computed tomography findings in patients with COVID-19

Cyrus Emir-Alavi, Zakiyeh Jafaryparvar, Mohammad Amin Khajavi Gaskarei, Sahar Heidary, Hossein Hemmati, Tofigh Yaghubi Kalurazi, Ali Alavi Foumani, Siamak Rimaz, Abbas Sedighi-Nejad, Hoda Sabati, Behnaz Ghanbar-Moghaddam, Hossein Khoshrang, Maryam Ahmadpour, Seyedeh Maral Mousavi, Zahra Golamalipour Garfami, Zobin Souri, Mohaya Farzin

Abstract


Due to the coronavirus disease (COVID-19) pandemic the high-resolution computed tomography (HRCT) become a relatively available and non-invasive method used for identifying COVID-19 cases. This study aimed to evalute HRCT findings of patients with COVID-19. Totally, 92 patients confirmed cases of COVID-19 by RT-PCR were included in the study. In addition to their demographic and clinical information, their  HRCT  findings were collected for evaluation. Among 92 patients (47 men, 45 women), the earliest symptoms included cough 81.5%, fever 67.4%, and muscle pain 58.7%. Six patients required intubation and mechanical ventilation at some point during their hospital stay. The most common  HRCT  findings in our study were grade 4 peripheral lesion 87%, bilateral 95.7%, mixed 76.08%, ground-glass opacity (GGOs) 75%, left lower lobe 94.56%. Among 92 patients, we had some inconsistent findings including two patients with cardiomegaly, three patients with pleural effusion, and bilateral pleural effusion in only one patient. According to the results, concluded that peripheral, bilateral, mixed, GGOs, left lower lobe involvement are important findings in most patients with COVID-19. We suspect that the disease has more severe lung involvement in men and less involvement in women, which needs further investigation.


Keywords


COVID-19; SARS-CoV-2; HRCT; Ground-glass opacity

Full Text:

Full-text PDF

References


Kannan S, Shaik Syed Ali P, Sheeza A, Hemalatha K. COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci. 2020;24(4):2006-11. doi: 10.26355/eurrev_202002_20378 PMID: 32141569

Sun J, He WT, Wang L, Lai A, Ji X, Zhai X, et al. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends Mol Med. 2020;26(5):483-95. doi: 10.1016/j.molmed.2020.02.008 PMID: 32359479

Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020;42(2):505-14. doi: 10.1007/s11357-020-00186-0 PMID: 32274617

Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102-8. doi: 10.1016/j.jpha.2020.03.001 PMID: 32282863

Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192-206. doi: 10.1111/joim.13091 PMID: 32348588

Sachs JD, Horton R, Bagenal J, Amor YB, Caman OK, Lafortune G. The Lancet COVID-19 Commission. The Lancet. 2020;396(10249):454-5. doi: 10.1016/S0140-6736(20)31494-X PMID: 32653081

Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281-6. doi: 10.1007/s12098-020-03263-6 PMID: 32166607

Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online. 2020;22:19. doi: 10.1186/s12575-020-00128-2 PMID: 32774178

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. doi: 10.1186/s40779-020-00240-0 PMID: 32169119

Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Lee SS. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020;24(7):4016-26. doi: 10.26355/eurrev_202004_20871 PMID: 32329877

Brauner M, Grenier P, Mompoint D, Lenoir S, De Cremoux H. Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology. 1989;172(2):467-71. doi: 10.1148/radiology.172.2.2748828 PMID: 2748828

Shan F, Gao Y, Wang J, Shi W, Shi N, Han M, et al. Lung infection quantification of COVID-19 in CT images with deep learning. arXiv preprint arXiv:200304655. 2020.

Montalbo FJ. Truncating fined-tuned vision-based models to lightweight deployable diagnostic tools for SARS-CoV-2 infected chest X-rays and CT-scans. Multimedia Tools and Applications. 2022. doi: 10.1007/s11042-022-12484-0 PMID: 35261555

Raghuvanshi V, Sood RG, Jhobta A, Sarkar M, Tomar A, Khanna S. Use of High-Resolution Computed Tomography (HRCT) in Diagnosis of Sputum Negative Pulmonary Tuberculosis. Turk Thorac J. 2016;17(2):59-64. doi: 10.5578/ttj.17.2.012 PMID: 29404125

Gao L, Zhang J. Pulmonary High-Resolution Computed Tomography (HRCT) Findings of Patients with Early-Stage Coronavirus Disease 2019 (COVID-19) in Hangzhou, China. Med Sci Monit. 2020;26:e923885. doi: 10.12659/msm.923885 PMID: 32246819

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. doi: 10.1056/NEJMoa2001017 PMID: 31978945

Majidi H, Bani-Mostafavi ES, Mardanshahi Z, Godazandeh F, Ghasemian R, Heydari K, et al. High-resolution computed tomography finding in 552 patients with symptomatic COVID-19: first report from north of Iran. Emerg Radiol. 2020;27(6):633-9. doi: 10.1007/s10140-020-01819-9 PMID: 32661945

Dai H, Zhang X, Xia J, Zhang T, Shang Y, Huang R, et al. High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China. Int J Infect Dis. 2020;95:106-12. doi: 10.1016/j.ijid.2020.04.003 PMID: 32272262

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. doi: 10.1056/NEJMoa2002032 PMID: 32109013

Chen Z, Fan H, Cai J, Li Y, Wu B, Hou Y, et al. High-resolution computed tomography manifestations of COVID-19 infections in patients of different ages. Eur J Radiol. 2020;126:108972. doi: 10.1016/j.ejrad.2020.108972 PMID: 32240913

Zamanian M, Foroozanfar Z, Izadi Z, Jafari S, Derakhshankhah H, Salimi M, et al. Association of Underlying Diseases and Clinical Characteristics with Mortality in Patients with 2019 Novel Coronavirus in Iran. Arch Clin Infect Dis. 2020;15(5):e104621. doi: 10.5812/archcid.104621

Chakraborty C, Sharma A, Sharma G, Bhattacharya M, Lee S. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020;24(7):4016-26.

Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, et al. Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CT. Radiology. 2020;296(2):E46-e54. doi: 10.1148/radiol.2020200823 PMID: 32155105

Muhammad SZ, Ahmed A, Shahid I, Khalid A, Menezes RG, Sheikh MU, et al. Chest computed tomography findings in hospitalized COVID-19 patients: a systematic review and meta-analysis. Infez Med. 2020;28(3):295-301. PMID: 32920564


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.